Marllon Cindra Sant’Ana

Mr. Marllon Cindra Sant’Ana


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2023 in Genes
Verified
Journal Article
Open access
PDF file
LALyvia Neves Rebello Alves
Lyvia Neves Rebello Alves
DMDébora Dummer Meira
Débora Dummer Meira
LMLuiza Poppe Merigueti
Luiza Poppe Merigueti
MCMatheus Correia Casotti
Matheus Correia Casotti
DVDiego Ventorim
Diego Ventorim
ILIuri Drumond Louro
Iuri Drumond Louro
Breast cancer is the second most frequent cancer in the world. It is a heterogeneous disease and the leading cause of cancer mortality in women. Advances in molecular technologies allowed for the identification of new and more specifics biomarkers for breast cancer diagnosis, prognosis, and risk prediction, enabling personalized treatments, improving therapy, and preventing overtreatment, undertreatment, and incorrect treatment. Several breast cancer biomarkers have been identified and, along with traditional biomarkers, they can assist physicians throughout treatment plan and increase therapy success. Despite the need of more data to improve specificity and determine the real clinical utility of some biomarkers, others are already established and can be used as a guide to make treatment decisions. In this review, we summarize the available traditional, novel, and potential biomarkers while also including gene expression profiles, breast cancer single-cell and polyploid giant cancer cells. We hope to help physicians understand tumor specific characteristics and support decision-making in patient-personalized clinical management, consequently improving treatment outcome.

1 February 2024 in RECIMA21 - Revista Científica Multidisciplinar
Verified
Journal Article
Open access
PDF file
YGYasmin Moreto Guaitolini
Yasmin Moreto Guaitolini
CCCamilly Victória Campanharo
Camilly Victória Campanharo
AMAntônio Vithor Prinz Moraes
Antônio Vithor Prinz Moraes
MSMarllon Cindra Sant’Ana
Marllon Cindra Sant’Ana
IPIsabele Pagani Pavan
Isabele Pagani Pavan
DMDébora Dummer Meira
Débora Dummer Meira
Biotechnology is the term given to the branch of science that employs knowledge, techniques, and genetic engineering methods for creating various products using living organisms as raw material. Although this term has been recently adopted, humans have long been manipulating biological processes for their own benefit. Biotechnology is multidisciplinary and encompasses various fields of knowledge, with significant progress achieved over the years, particularly in the medical and cosmetic sectors. Through genetic engineering, it has become possible to edit genes more precisely, revolutionizing the study and manipulation of DNA and allowing the proposal and use of strategies that were once unthinkable in the scientific field to address contemporary issues. Among its most recent contributions are the development of new drugs and biopharmaceuticals, vaccines, cellular, genetic, and protein therapies, as well as the production of biocosmetics. However, there are still challenges to be faced in the extensive use of genetic engineering, ranging from production costs and the success of the technique at the molecular level to ethical issues surrounding the application of this technology. Thus, this literature review aims to discuss the most recent advances, applications, and future perspectives of biotechnology and genetic engineering in the scientific field.

4 July 2026 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PLPedro Piovesan Lago
Pedro Piovesan Lago
Mariana MaschiettoMariana Maschietto
Mariana Maschietto
MSMarllon Cindra Sant’Ana
Marllon Cindra Sant’Ana
CFCarlos Eduardo Ramos Fernandes
Carlos Eduardo Ramos Fernandes
JCJoão Victor Alves de Castro
João Victor Alves de Castro
Elvis Terci ValeraElvis Terci Valera
Elvis Terci Valera
Molecular subgroups of ependymomas are strongly associated with their primary anatomical compartments, namely the supratentorial region, posterior fossa and spine locations. Although it is generally accepted that posterior fossa ependymomas may arise from radial glia-like progenitor cells, the precise cellular origin of the distinct posterior fossa molecular subgroups remains to be determined. Given that DNA methylation profile strongly recapitulates developmental lineage and the cell of origin, the characterization of unexpectedly located molecular subgroups of ependymomas may provide insights into their cells of origin and potential migratory dynamics during embryogenesis and brain development. Herein, we describe two male school-aged pediatric patients with supratentorial tumors located in the third ventricle/pineal region that were classified as posterior fossa group B ependymomas based on DNA methylation profiling. To our knowledge, this represents the first reports of posterior fossa group B ependymomas identified outside the posterior fossa compartment.

24 April 2026 in Pediatric Blood & Cancer
Verified
Journal Article
Open access
MSMarllon Cindra Sant’Ana
Marllon Cindra Sant’Ana
Mariana MaschiettoMariana Maschietto
Mariana Maschietto
DLDaniela Paz Leal
Daniela Paz Leal
RORicardo de Santos de Oliveira
Ricardo de Santos de Oliveira
MEMayara Euzebio
Mayara Euzebio
Elvis Terci ValeraElvis Terci Valera
Elvis Terci Valera